Stuka Paul 4/A
4/A · InspireMD, Inc. · Filed Feb 23, 2026
Research Summary
AI-generated summary of this filing
InspireMD (NSPR) Director Paul Stuka Buys 2,710 Shares
What Happened
Paul Stuka, a director of InspireMD, acquired 2,710 shares in an open-market purchase on December 9, 2025. The reported weighted average price was $1.81 per share, for a total cost of approximately $4,905. This was a purchase (transaction code P), which some investors view as a mildly bullish signal, though the dollar amount is modest.
Key Details
- Transaction date: December 9, 2025.
- Price: Weighted average $1.81 per share (footnote indicates trades ranged $1.80–$1.81; full breakdown available on request).
- Shares acquired: 2,710; total reported value: $4,905.
- Shares owned after transaction: Not disclosed in this amended filing.
- Filing: This is an amended Form 4 (filed Feb 23, 2026) that corrects the number of shares reported in Table I, Column 4; the original Form 4 was filed Dec 11, 2025 and no other changes were made (Exhibit 24.1: Power of Attorney included).
- Transaction code: P = Purchase.
Context
The purchase is small in dollar terms and is an open-market buy (not an option exercise, gift, or award). The amendment corrects a reporting detail rather than altering the nature of the trade. As always, insider purchases are factual signals of ownership change but do not by themselves explain motivation or predict future stock performance.
Insider Transaction Report
- Purchase
Common Stock
[F1][F2]2025-12-09$1.81/sh+2,710$4,905→ 391,628 total
Footnotes (2)
- [F1]This Form 4/A amends the Form 4 filed on December 11, 2025 solely to correct the number of shares reported in Table I, Column 4. The number of shares reported in Column 5 was correct as originally filed. No other changes have been made.
- [F2]The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.80 to $1.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.